🇺🇸 FDA
Patent

US 11865122

Estrogen therapy for brain gray matter atrophy and associated disability

granted A61KA61K31/565A61K31/566

Quick answer

US patent 11865122 (Estrogen therapy for brain gray matter atrophy and associated disability) held by The Regents of the University of California expires Mon Jan 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jan 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K31/565, A61K31/566, A61K31/57, A61K49/06